Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01235065 · ClinicalTrials.gov registry record · NA

GlideScope Versus Direct Laryngoscope for Emergency Intubation

A NA study of Oral Intubation, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
623
Enrollment target
1
Study location

NCT01235065: Completed NA study of Oral Intubation, sponsored by University of Maryland, Baltimore.

NCT01235065 is a NA study of Oral Intubation that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 623 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01235065, a NA study of Oral Intubation, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
623 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess if the GlideScope video laryngoscope is superior to the Macintosh direct laryngoscope for definitive airway management in acutely-injured patients.

Primary Outcome

Assessment of whether or not the patient was discharged alive from the study center

Conditions Studied

Interventions

  • DEVICE type of laryngoscope

Study Locations (1)

Maryland

  • R Adams Cowley Shock Trauma Center - Baltimore

Trial Details

FieldValue
Enrollment Target 623 participants
Start Date 2008-07
Est. Completion 2016-11-16
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT01235065 record still lists

NCT01235065 is an interventional study that assigns participants to a tested intervention. The registered 623 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).

The record links to 1 condition, with Oral Intubation appearing as the primary indexed condition, and to 1 intervention - of which type of laryngoscope is the first listed.

NCT01235065 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01235065 about?

NCT01235065 is a clinical study titled "GlideScope Versus Direct Laryngoscope for Emergency Intubation". The purpose of this study is to assess if the GlideScope video laryngoscope is superior to the Macintosh direct laryngoscope for definitive airway management in acutely-injured patients.

What is the current status of trial NCT01235065?

This trial is currently completed. It is a NA study. The enrollment target is 623 participants. The study started on 2008-07. Estimated completion is 2016-11-16.

What conditions does trial NCT01235065 study?

This clinical trial studies the following conditions: Oral Intubation.

What interventions are being tested in trial NCT01235065?

The interventions under investigation include: type of laryngoscope (DEVICE).

Who is sponsoring clinical trial NCT01235065?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01235065 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01235065's enrollment target sits among peer trials

623 161st of 2000 higher than 1,840 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06406049 · 624 participants · NA

    Finishing HIV Project

  • NCT05349227 · 625 participants · NA

    Comprehensive Outcomes for After Cancer Health

  • NCT06103864 · 625 participants · Phase 3

    A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

  • NCT06230510 · 625 participants · NA

    Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01235065, the US trial registry maintained by the National Library of Medicine. NCT01235065 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.